RO92333B1 - Tumoral cell radiosensitizing product - Google Patents

Tumoral cell radiosensitizing product

Info

Publication number
RO92333B1
RO92333B1 RO119193A RO11919385A RO92333B1 RO 92333 B1 RO92333 B1 RO 92333B1 RO 119193 A RO119193 A RO 119193A RO 11919385 A RO11919385 A RO 11919385A RO 92333 B1 RO92333 B1 RO 92333B1
Authority
RO
Romania
Prior art keywords
product
neoplasm
radiation
various forms
cancer
Prior art date
Application number
RO119193A
Other languages
Romanian (ro)
Other versions
RO92333A2 (en
Inventor
Constantin Vladescu
Original Assignee
Institutul De Cercetari Chimico-Farmaceutice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institutul De Cercetari Chimico-Farmaceutice filed Critical Institutul De Cercetari Chimico-Farmaceutice
Priority to RO119193A priority Critical patent/RO92333B1/en
Publication of RO92333A2 publication Critical patent/RO92333A2/en
Publication of RO92333B1 publication Critical patent/RO92333B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia se refera la un produs radiosensibilizator al celulelor tumorale, utilizat în radioterapia diverselor forme de neoplasm, constituit din acid ascorbic, sulfat de p-metilaminofenol, acid p-aminobenzoic si hidrochinona. Produsul se administreaza usor, utilizat în asociere cu radioterapia conventionala sensibilizeaza selectiv tumoral, fata de acest tratament fara a avea efecte toxice asupra organismului, permite tratamentul ambulatoriu si de lunga durata, conducand la scurgerea perioadei si a zozei totale de iradiere, cresterea gradului de vindecare a diverselor forme de neoplasm si convertirea formelor de cancer înoperabil în cancer operabil.The invention relates to a tumor cell radiosensitizer used in radiotherapy of various forms of neoplasm, consisting of ascorbic acid, p-methylaminophenol sulfate, p-aminobenzoic acid and hydroquinone. The product is easy to administer, used in combination with conventional radiotherapy, selectively sensitizes the tumor, this treatment without toxic effects on the body, allows outpatient and long-term treatment, leading to leakage of the total period of radiation and radiation, increased healing the various forms of neoplasm and the conversion of cancer forms intooperable into operable cancer.

RO119193A 1985-06-18 1985-06-18 Tumoral cell radiosensitizing product RO92333B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO119193A RO92333B1 (en) 1985-06-18 1985-06-18 Tumoral cell radiosensitizing product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO119193A RO92333B1 (en) 1985-06-18 1985-06-18 Tumoral cell radiosensitizing product

Publications (2)

Publication Number Publication Date
RO92333A2 RO92333A2 (en) 1987-08-31
RO92333B1 true RO92333B1 (en) 1987-09-01

Family

ID=20117434

Family Applications (1)

Application Number Title Priority Date Filing Date
RO119193A RO92333B1 (en) 1985-06-18 1985-06-18 Tumoral cell radiosensitizing product

Country Status (1)

Country Link
RO (1) RO92333B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ1781A1 (en) * 1993-05-21 2002-02-17 Radopah Ltd Arylating agents.

Also Published As

Publication number Publication date
RO92333A2 (en) 1987-08-31

Similar Documents

Publication Publication Date Title
EP0151989A3 (en) Means for the treatment of cardiac diseases
ES8609365A1 (en) Novel CSF and method for obtaining the same.
ZA7468B (en) Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors
DE69330032D1 (en) THERAPEUTIC COMBINATION PREPARATION CONTAINING INTERFERON
IT8322630A0 (en) MEDICINAL PREPARATION TO IMPROVE CANCER SYMPTOMS.
IE851929L (en) Cancer therapy
ES8706965A1 (en) Method of forming a metal chelate protein conjugate.
ZA856118B (en) Treatment of cancer with phlorizin and its derivatives
JPS5735516A (en) Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
EP0034214A3 (en) Use of rosmarinic acid in the treatment of inflammations and pharmaceutical products used therein
RO92333B1 (en) Tumoral cell radiosensitizing product
ES2115582T3 (en) PREPARATION AND APPLICATIONS OF INTERFERON-GAMMA.
ES8707565A1 (en) Monoclonal antibodies to tissue plasminogen activator derived from human normal cells.
ES8704962A1 (en) 1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans.
ES2012547A6 (en) Use of metalloporphyrins to reverse the toxic effect of tumor therapy.
IT1148021B (en) PROCEDURE FOR THE MANUFACTURE OF THE STIMULATING ACTIVITY FACTOR OF CELL MULTIPLICATION IN MEN
DE69232852D1 (en) USE OF TOPOTECAN IN THE TREATMENT OF NON-SMALL CELL LUNG CARCINOMAS
SU1271520A1 (en) Immunostimulator
IT8819410A0 (en) PROCEDURE TO INCREASE THE EFFECTIVENESS OF IN VITRO VEGETATIVE PROPAGATION OF POTATOES.
JPS57159715A (en) Synergism of analgesic
ATE87314T1 (en) PLATINUM MEDICINES.
FUKUSHIMA Some Supplements to the" Polysaccharide Hypothesis" Concerning the Development, Therapy and Prophylaxis of Cancer
IT8221375A0 (en) TOPICAL COSMETIC PREPARATIONS FOR THE TREATMENT OF SEBORHEA.
DE3582044D1 (en) THERAPEUTIC USE OF CYPROTERONE ACETATE.
DK222988A (en) PHARMACEUTICAL PREPARATIONS CONTAINING ORNITHIN-DECARBOXYLASE INHIBITORS